Artiva Biotherapeutics Insider Trades

ARTV

Track insider trading activity from Artiva Biotherapeutics executives and directors. See which insiders are buying and selling ARTV stock.

Trades Last 12 Months

ARTV Price

All Insider Trades for Artiva Biotherapeutics

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Holding Value $164M 16,763,043 shares
Last Trade
Jun 16, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.11M 124,893 shares
$8.89
$9.80
Raymon Heather Svp, Research And Development
Holding Value $1.45M 148,228 shares
Last Trade
May 19, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$27.9k 3,095 shares
$9.01
$9.80
Banerjee Subhashis Chief Medical Officer
Holding Value $1.42M 144,963 shares
Last Trade
May 19, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$63.4k 7,037 shares
$9.01
$9.80
Bush Jennifer Coo, Clo, Compliance Officer
Holding Value $3.31M 337,920 shares
Last Trade
May 19, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$79.2k 8,790 shares
$9.01
$9.80
Horan Christopher Chief Tech Operations Officer
Holding Value $2.88M 293,450 shares
Last Trade
May 19, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$63.1k 7,002 shares
$9.01
$9.80
Aslan Fred Chief Executive Officer
Holding Value $15M 1,535,082 shares
Last Trade
May 19, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$244k 27,116 shares
$9.01
$9.80
Miralles Gines Diego President & Head Of R&d
Holding Value $2.28M 232,500 shares
Last Trade
May 18, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.86M 310,000 shares
$9.22
$9.80
Gc Corp. 10% owner
Holding Value $15.8M 1,607,734 shares
Last Trade
May 11, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$4M 347,222 shares
$11.52
$9.80
Holding Value $149M 15,203,995 shares
Last Trade
May 11, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$75M 6,510,416 shares
$11.52
$9.80
Huston Thad Allen Chief Financial Officer
Holding Value $2.16M 220,000 shares
Last Trade
Mar 10, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.34M 220,000 shares
$6.08
$9.80
Sorg Elaine K. Director
Holding Value $270k 27,500 shares
Last Trade
Feb 18, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$114k 27,500 shares
$4.15
$9.80
Krishnamohan Neha Chief Financial Officer
Holding Value $974k 99,356 shares
Last Trade
Nov 15, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$11.3k 3,490 shares
$3.25
$9.80
Moore Alison Director
Holding Value $135k 13,750 shares
Last Trade
Jun 24, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$22.1k 13,750 shares
$1.61
$9.80
Daniels Brian Director
Holding Value $135k 13,750 shares
Last Trade
Jun 24, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$22.1k 13,750 shares
$1.61
$9.80
Stoppel Laura Director
Holding Value $135k 13,750 shares
Last Trade
Jun 24, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$22.1k 13,750 shares
$1.61
$9.80
Baker Daniel G. Director
Holding Value $135k 13,750 shares
Last Trade
Jun 24, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$22.1k 13,750 shares
$1.61
$9.80
Holding Value $135k 13,750 shares
Last Trade
Jun 24, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$22.1k 13,750 shares
$1.61
$9.80
Graef Thorsten Chief Medical Officer
Holding Value $784k 80,000 shares
Last Trade
Feb 26, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$232k 60,000 shares
$3.86
$9.80
Huh Yong Jun Director
Holding Value $32.4M 3,306,900 shares
Last Trade
Jul 22, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$25M 2,083,332 shares
$12.00
$9.80
Holding Value $1.9M 194,108 shares
Last Trade
Jul 22, 2024 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$577k 49,019 shares
$11.77
$9.80

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up